Showing results (41-50 of 169) with videos related to

Sort By:
Pageof 17
Hormone Research in Paediatrics|July 23, 2011
Lessons learned from 15 years of KIMS and 5 years of ACROSTUDYAnton Luger, Ulla Feldt-Rasmussen, Roger Abs, et al.
Diabetes, Obesity & Metabolism|February 18, 2017
Preclinical characterization of 55P0251, a novel compound that amplifies glucose-stimulated insulin secretion and counteracts hyperglycaemia in rodentsKarin Stadlbauer, Barbara Brunmair, Zsuzsanna Lehner, et al.
European Journal of Endocrinology|September 16, 2015
Proposal of a clinical response score and predictors of clinical response to 2 years of GH replacement therapy in adult GH deficiencyHarald J Schneider, Michael Buchfelder, Henri Wallaschofski, et al.
Clinical Case Reports|January 31, 2020
Ectopic Cushing's syndrome in a patient with inferior petrosal sinus sampling indicating pituitary-dependent ACTH secretionAlexander Micko, Stefan Wolfsberger, Engelbert Knosp, et al.
Diabetes Care|November 15, 2011
Incidence of diabetes mellitus and evolution of glucose parameters in growth hormone-deficient subjects during growth hormone replacement therapy: a long-term observational studyAnton Luger, Anders F Mattsson, Maria Koltowska-Häggström, et al.
Wiener Klinische Wochenschrift|May 18, 2004
Normal regulation of elevated plasma ghrelin concentrations in dialysis patientsAdele Schmidt, Veronika Fabrizii, Christina Maier, et al.
Diabetes|June 24, 2008
Cholinergic regulation of ghrelin and peptide YY release may be impaired in obesityChristina Maier, Michaela Riedl, Greisa Vila, et al.
The British Journal of Nutrition|August 25, 2015
Lactation and appetite-regulating hormones: increased maternal plasma peptide YY concentrations 3-6 months postpartumGreisa Vila, Judith Hopfgartner, Gabriele Grimm, et al.
Endocrine Pathology|July 1, 1995
Lymphocytic Hypophysitis Presenting as a Pituitary Tumor in a 63-Year-Old ManMichaela Riedl, Thomas Czech, Jaqueline Slootweg, et al.
American Journal of Physiology. Cell Physiology|February 25, 2011
Lipophilicity as a determinant of thiazolidinedione action in vitro: findings from BLX-1002, a novel compound without affinity to PPARsBarbara Brunmair, Katrin Staniek, Zsuzsanna Lehner, et al.
Pageof 17